Correlation Between Formosa Laboratories and SCI Pharmtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Formosa Laboratories and SCI Pharmtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Formosa Laboratories and SCI Pharmtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Formosa Laboratories and SCI Pharmtech, you can compare the effects of market volatilities on Formosa Laboratories and SCI Pharmtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Formosa Laboratories with a short position of SCI Pharmtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Formosa Laboratories and SCI Pharmtech.

Diversification Opportunities for Formosa Laboratories and SCI Pharmtech

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Formosa and SCI is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Formosa Laboratories and SCI Pharmtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCI Pharmtech and Formosa Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Formosa Laboratories are associated (or correlated) with SCI Pharmtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCI Pharmtech has no effect on the direction of Formosa Laboratories i.e., Formosa Laboratories and SCI Pharmtech go up and down completely randomly.

Pair Corralation between Formosa Laboratories and SCI Pharmtech

Assuming the 90 days trading horizon Formosa Laboratories is expected to under-perform the SCI Pharmtech. In addition to that, Formosa Laboratories is 1.91 times more volatile than SCI Pharmtech. It trades about -0.19 of its total potential returns per unit of risk. SCI Pharmtech is currently generating about 0.06 per unit of volatility. If you would invest  8,780  in SCI Pharmtech on September 15, 2024 and sell it today you would earn a total of  280.00  from holding SCI Pharmtech or generate 3.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Formosa Laboratories  vs.  SCI Pharmtech

 Performance 
       Timeline  
Formosa Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Formosa Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
SCI Pharmtech 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in SCI Pharmtech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, SCI Pharmtech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Formosa Laboratories and SCI Pharmtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Formosa Laboratories and SCI Pharmtech

The main advantage of trading using opposite Formosa Laboratories and SCI Pharmtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Formosa Laboratories position performs unexpectedly, SCI Pharmtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCI Pharmtech will offset losses from the drop in SCI Pharmtech's long position.
The idea behind Formosa Laboratories and SCI Pharmtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope